Fabry disease. A potential pitfall A family with a novel intronic mutation
- PMID: 30211005
- PMCID: PMC6129647
- DOI: 10.1016/j.ymgmr.2018.07.001
Fabry disease. A potential pitfall A family with a novel intronic mutation
Abstract
Fabry disease is a genetic disorder characterized by the accumulation of globotriaosylceramide in cell lysosomes resulting from an X-linked deficiency of α-galactosidase A activity. It presents with multiorgan manifestations, including progressive renal disease, cardiomyopathy and premature demise. Recently, its prevalence has been reported to be higher in hemodialysis (HD) patients than in the general population. We report two cases of homozygous patients with an intronic alpha-galactosidase gene mutation and a classic phenotype of the disease. One of the patients had a kidney transplant and the donor was his brother, before Fabry disease were diagnose.
References
-
- Desnick R.J., Ioannou Y.A., Eng C.M. α-Galactosidase A deficiency: Fabry disease. In: Scriver C.R., Beaudet A.L., Sly W.S., Valle D., editors. The Metabolic Bases of Inherited Disease. 8th ed. MacGraw-Hill; New York: 2001. pp. 3733–3774.
-
- Aerts J.M., Groener J.E., Kuiper S., Donker-Koopman W.E., Strijland A., Ottenhoff R., van Roomen C., Mirzaian M., Wijburg F.A., Linthorst G.E., Vedder A.C., Rombach S.M., Cox-Brinkman J., Somerharju P., Boot R.G., Hollak C.E., Brady R.O., Poorthuis B.J. Elevated globotriaosylsphingosine is a hallmark of fabry disease. Proc. Natl. Acad. Sci. U. S. A. 2008;105(8):2812–2817. - PMC - PubMed
-
- Meikle P.J., Hopwood J.J., Clague A.E., Wf Carey. Prevalence of lysosomal storage disorders. JAMA. 1999;281:249–254. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources